References

  1. Lambert R, H Saito, E Lucas, and R Sankaranarayanan. Survival from digestive cancer in emerging countries in Asia and Africa. Eur J Gastroenterol Hepatol. 2012; 24(6): 605-12. PubMed | Google Scholar

  2. Ferlay J, HR Shin, F Bray, D Forman, C Mathers, and DM Parkin. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917. PubMed | Google Scholar

  3. Registre des Cancers de Rabat, 2012. Google Scholar

  4. Vizcaino AP, V Moreno, R Lambert, and DM Parkin. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer. 2002; 99(6): 860-8. PubMed | Google Scholar

  5. Herskovic A, K Martz, M al-Sarraf, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992; 326(24): 1593-8. PubMed | Google Scholar

  6. Sagar PM, T Gauperaa, H Sue-Ling, MJ McMahon, and D Johnston. An audit of the treatment of cancer of the oesophagus. Gut. 1994; 35(7): 941-5. PubMed | Google Scholar

  7. Bhatt L, S Tirmazy, and S Sothi. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center. Dis Esophagus. 2013; 26(1): 57-60. PubMed | Google Scholar

  8. Homs MY, EW Steyerberg, WM Eijkenboom, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lance. 2004; 364(9444): 1497-504. PubMed | Google Scholar

  9. Steyerberg EW, Homs MY, Stokvis A, Essink-Bot ML , and Siersema PD. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc. 2005; 62(3): 333-40. PubMed | Google Scholar

  10. Amdal CD, Jacobsen B, Sandstad T, Warloe, and Bjordal K. Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial. Radiother Oncol. 2013; 107(3):428-33. PubMed | Google Scholar

  11. Lindenmann J, Matzi V, Neuboeck N, et al. Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival. Lasers Surg Med. 2012; 44(3): 189-98. PubMed | Google Scholar

  12. Rupinski M, Zagorowicz E, Regula J et al. Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II). Am J Gastroenterol. 2011; 106(9): 1612-20. PubMed | Google Scholar

  13. Rosenblatt E G, Jones RK, Sur et al. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol. 2010; 97(3): 488-94. PubMed | Google Scholar

  14. Kanaev SV, Shcherbakov AM, and Shulepov AV. Combined radiotherapy for inoperable esophageal cancer. Vopr Onkol. 2006; 52(1): 32-7. PubMed | Google Scholar

  15. Sur R, Donde B, Falkson C, et al. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy. 2004; 3(4): 191-5. PubMed | Google Scholar

  16. Sreedharan A, Harris K , Crellin A, Forman D, and Everett SM. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2009; (4):CD005048. PubMed | Google Scholar

  17. Cesas A, and Bagajevas A. Combined treatment of esophageal cancer: a review. Medicina (Kaunas). 2004; 40 (Suppl 1): 161-5. PubMed | Google Scholar

  18. Sgourakis G, Gockel I, Radtke A, et al. The use of self-expanding stents in esophageal and gastroesophageal junction cancer palliation: a meta-analysis and meta-regression analysis of outcomes. Dig Dis Sci. 2010; 55(11): 3018-30. PubMed | Google Scholar

  19. Homs MY, Steyerberg EW , Eijkenboom WM, and Siersema PD. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer. Brachytherapy. 2006; 5(1): 41-8. PubMed | Google Scholar

  20. Frobe A, Jones G, Jaksic B, et al. Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus. Dis Esophagus. 2009; 22(6): 513-8. PubMed | Google Scholar

  21. Homs MY, Eijkenboom WM , and Siersema PD. Single-dose brachytherapy for the palliative treatment of esophageal cancer. Endoscopy. 2005; 37(11): 1143-8. PubMed | Google Scholar

  22. Sur RK, Levin CV , Donde B, Sharma V, Miszczyk L, and Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002; 53(1): 127-33. PubMed | Google Scholar

  23. Jager J, Langendijk H, Pannebakker M, Rijken J, and de Jong J. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol. 1995; 37(3): 237-40. PubMed | Google Scholar

  24. Wong S, Hennequin C, and Quero L. Brachytherapy for oesophageal cancer. Cancer Radiother. 2013; 17(2): 159-61. PubMed | Google Scholar

  25. Sharma V, Mahantshetty U, Dinshaw KA, Deshpande R, and Sharm S. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2002; 52(2): 310-5. PubMed | Google Scholar